Smoller David Adam 4/A
4/A · SIGMA ALDRICH CORP · Filed Nov 4, 2011
Insider Transaction Report
Form 4/AAmended
Smoller David Adam
President, Research Biotech
Transactions
- Exercise/Conversion
Common Stock
2011-10-28$37.56/sh+2,100$78,876→ 12,104 total - Sale
Common Stock
2011-10-28$68.33/sh−2,100$143,497→ 10,004 total - Exercise/Conversion
NQ Stock Option Right to Buy
2011-10-28−2,100→ 3,472 totalExercise: $37.56From: 2010-02-17Exp: 2019-02-17→ Common Stock (2,100 underlying) - Sale
Common Stock
2011-10-28$68.33/sh−700$47,829→ 9,304 total